1. Home
  2. NRIX vs IIIN Comparison

NRIX vs IIIN Comparison

Compare NRIX & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRIX
  • IIIN
  • Stock Information
  • Founded
  • NRIX 2009
  • IIIN 1953
  • Country
  • NRIX United States
  • IIIN United States
  • Employees
  • NRIX N/A
  • IIIN N/A
  • Industry
  • NRIX Biotechnology: Pharmaceutical Preparations
  • IIIN Steel/Iron Ore
  • Sector
  • NRIX Health Care
  • IIIN Industrials
  • Exchange
  • NRIX Nasdaq
  • IIIN Nasdaq
  • Market Cap
  • NRIX 750.4M
  • IIIN 606.6M
  • IPO Year
  • NRIX 2020
  • IIIN N/A
  • Fundamental
  • Price
  • NRIX $16.85
  • IIIN $30.52
  • Analyst Decision
  • NRIX Strong Buy
  • IIIN
  • Analyst Count
  • NRIX 14
  • IIIN 0
  • Target Price
  • NRIX $26.29
  • IIIN N/A
  • AVG Volume (30 Days)
  • NRIX 1.8M
  • IIIN 125.2K
  • Earning Date
  • NRIX 10-09-2025
  • IIIN 10-16-2025
  • Dividend Yield
  • NRIX N/A
  • IIIN 3.65%
  • EPS Growth
  • NRIX N/A
  • IIIN 112.14
  • EPS
  • NRIX N/A
  • IIIN 2.10
  • Revenue
  • NRIX $83,687,000.00
  • IIIN $647,706,000.00
  • Revenue This Year
  • NRIX $58.48
  • IIIN $14.97
  • Revenue Next Year
  • NRIX N/A
  • IIIN $7.00
  • P/E Ratio
  • NRIX N/A
  • IIIN $14.60
  • Revenue Growth
  • NRIX 48.32
  • IIIN 22.39
  • 52 Week Low
  • NRIX $8.18
  • IIIN $22.49
  • 52 Week High
  • NRIX $23.09
  • IIIN $41.64
  • Technical
  • Relative Strength Index (RSI)
  • NRIX 80.15
  • IIIN 37.94
  • Support Level
  • NRIX $12.43
  • IIIN $30.11
  • Resistance Level
  • NRIX $13.43
  • IIIN $32.87
  • Average True Range (ATR)
  • NRIX 0.97
  • IIIN 0.79
  • MACD
  • NRIX 0.32
  • IIIN 0.09
  • Stochastic Oscillator
  • NRIX 98.68
  • IIIN 25.25

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

Share on Social Networks: